XML 15 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Flows From Operating Activities    
Net income (loss) $ (72,534) $ 44,521
Adjustments to reconcile net income to net cash provided by operating activities    
Net accretion of bond premium 3,008 2,763
Depreciation and amortization 1,636 1,166
Stock-based compensation expense 1,634 2,688
Net realized investment (gains) losses 93,407 (26,713)
Net cash flows from equity and trading investments 2,156 1,235
Deferred income tax benefit (21,803) 4,863
Changes in:    
Accrued investment income (11) (709)
Premiums receivable (5,570) (18,361)
Deferred policy acquisition costs (43) (3,095)
Reinsurance receivables (26,026) 4,720
Prepaid reinsurance premiums (2,139) (443)
Income taxes receivable (15,150) 10,647
Other assets (7,126) (21,034)
Losses and loss settlement expenses 16,651 (8,987)
Unearned premiums 15,798 17,795
Accrued expenses and other liabilities (1,958) 1,275
Deferred income taxes 4,463 0
Other, net 11,120 (1,628)
Cash from operating activities 70,047 (33,818)
Net cash provided by (used in) operating activities (2,487) 10,703
Cash Flows From Investing Activities    
Proceeds from sale of available-for-sale investments 11,910 36,490
Proceeds from call and maturity of available-for-sale investments 68,976 38,740
Proceeds from short-term and other investments 1,889 1,027
Purchase of available-for-sale investments (57,182) (25,007)
Purchase of mortgage loans (2,746) (8,496)
Purchase of short-term and other investments (1,469) (3,311)
Net purchases and sales of property and equipment (7,144) (12,017)
Net cash provided by investing activities 14,234 27,426
Cash Flows From Financing Activities    
Payment of cash dividends (8,249) (7,797)
Repurchase of common stock (2,741) 0
Issuance of common stock (755)  
Issuance of common stock   750
Net cash used in financing activities (11,745) (7,047)
Net Change in Cash and Cash Equivalents 2 31,082
Cash and Cash Equivalents at Beginning of Period 120,722 64,454
Cash and Cash Equivalents at End of Period $ 120,724 $ 95,536